Please login to the form below

Not currently logged in
Email:
Password:

ulipristal acetate

This page shows the latest ulipristal acetate news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Allergan’s uterine fibroid drug over safety concerns

FDA rejects Allergan’s uterine fibroid drug over safety concerns

Allergan’s selective progesterone receptor modulator is already approved in Europe, where it is sold as Esmya (ulipristal acetate) and marketed by Hungarian pharmaceutical company Gedeon Richter. ... next steps for ulipristal acetate NDA”.

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The pill branding The pill branding

    In the UK, Levonelle with the active ingredient levonorgestrel and ellaOne containing ulipristal acetate are sold over the counter to girls over 16 since 2001. ... the binding landmark decision of switching the ellaOne (ulipristal acetate) pill to an OTC

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics